Results
|
|
4781.
|
|
|
|
4782.
|
Phase I study of sequentially administered topoisomerase I inhibitor (irinotecan) and topoisomerase II inhibitor (etoposide) for metastatic non-small-cell lung cancer. [electronic resource] by
- Ando, M
- Eguchi, K
- Shinkai, T
- Tamura, T
- Ohe, Y
- Yamamoto, N
- Kurata, T
- Kasai, T
- Ohmatsu, H
- Kubota, K
- Sekine, I
- Hojo, N
- Matsumoto, T
- Kodama, T
- Kakinuma, R
- Nishiwaki, Y
- Saijo, N
Producer: 19980108
In:
British journal of cancer vol. 76
Availability: No items available.
|
|
|
4783.
|
|
|
|
4784.
|
|
|
|
4785.
|
|
|
|
4786.
|
|
|
|
4787.
|
|
|
|
4788.
|
|
|
|
4789.
|
Multimodal therapy with intravenous biweekly leucovorin, 5-fluorouracil and irinotecan combined with hepatic arterial infusion pirarubicin in non-resectable hepatic metastases from colorectal cancer (a European Association for Research in Oncology trial). [electronic resource] by
- Zelek, L
- Bugat, R
- Cherqui, D
- Ganem, G
- Valleur, P
- Guimbaud, R
- Dupuis, O
- Aziza, T
- Fagniez, P L
- Auroux, J
- Kobeiter, H
- Tayar, C
- Braud, A C
- Haddad, E
- Piolot, A
- Buyse, M
- Piedbois, P
Producer: 20040319
In:
Annals of oncology : official journal of the European Society for Medical Oncology vol. 14
Availability: No items available.
|
|
|
4790.
|
|
|
|
4791.
|
|
|
|
4792.
|
|
|
|
4793.
|
|
|
|
4794.
|
|
|
|
4795.
|
|
|
|
4796.
|
Irinophore C, a novel nanoformulation of irinotecan, alters tumor vascular function and enhances the distribution of 5-fluorouracil and doxorubicin. [electronic resource] by
- Baker, Jennifer H E
- Lam, Jeffrey
- Kyle, Alaistair H
- Sy, Jonathan
- Oliver, Thomas
- Co, Steven J
- Dragowska, Wieslawa H
- Ramsay, Euan
- Anantha, Malathi
- Ruth, Thomas J
- Adam, Michael J
- Yung, Andrew
- Kozlowski, Piotr
- Minchinton, Andrew I
- Ng, Sylvia S W
- Bally, Marcel B
- Yapp, Donald T T
Producer: 20090105
In:
Clinical cancer research : an official journal of the American Association for Cancer Research vol. 14
Availability: No items available.
|
|
|
4797.
|
|
|
|
4798.
|
Predictive biomarkers of chemotherapy efficacy in colorectal cancer: results from the UK MRC FOCUS trial. [electronic resource] by
- Braun, Michael S
- Richman, Susan D
- Quirke, Philip
- Daly, Catherine
- Adlard, Julian W
- Elliott, Faye
- Barrett, Jennifer H
- Selby, Peter
- Meade, Angela M
- Stephens, Richard J
- Parmar, Mahesh K B
- Seymour, Matthew T
Producer: 20080625
In:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology vol. 26
Availability: No items available.
|
|
|
4799.
|
Pharmacogenetic assessment of toxicity and outcome in patients with metastatic colorectal cancer treated with LV5FU2, FOLFOX, and FOLFIRI: FFCD 2000-05. [electronic resource] by
- Boige, Valérie
- Mendiboure, Jean
- Pignon, Jean-Pierre
- Loriot, Marie-Anne
- Castaing, Marine
- Barrois, Michel
- Malka, David
- Trégouët, David-Alexandre
- Bouché, Olivier
- Le Corre, Delphine
- Miran, Isabelle
- Mulot, Claire
- Ducreux, Michel
- Beaune, Philippe
- Laurent-Puig, Pierre
Producer: 20100908
In:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology vol. 28
Availability: No items available.
|
|
|
4800.
|
|